FDA Inspection 826551 — Eurofins Biopharma Product Testing Ireland Limited
The FDA completed an inspection of Eurofins Biopharma Product Testing Ireland Limited on March 29, 2013 in Dungarvan. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 29, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Dungarvan (Ireland)